Rücker, Frank G.
Du, Ling
Luck, Tamara J.
Benner, Axel http://orcid.org/0000-0002-7238-6956
Krzykalla, Julia
Gathmann, Insa
Voso, Maria Teresa http://orcid.org/0000-0002-6164-4761
Amadori, Sergio
Prior, Thomas W.
Brandwein, Joseph M.
Appelbaum, Frederick R.
Medeiros, Bruno C. http://orcid.org/0000-0001-6972-8137
Tallman, Martin S.
Savoie, Lynn
Sierra, Jorge
Pallaud, Celine
Sanz, Miguel A. http://orcid.org/0000-0003-1489-1177
Jansen, Joop H.
Niederwieser, Dietger http://orcid.org/0000-0002-4737-1103
Fischer, Thomas
Ehninger, Gerhard
Heuser, Michael http://orcid.org/0000-0001-5318-9044
Ganser, Arnold
Bullinger, Lars
Larson, Richard A. http://orcid.org/0000-0001-9168-3203
Bloomfield, Clara D. http://orcid.org/0000-0001-5465-7591
Stone, Richard M.
Döhner, Hartmut
Thiede, Christian http://orcid.org/0000-0003-1241-2048
Döhner, Konstanze http://orcid.org/0000-0002-2261-9862
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1074, project B3)
Article History
Received: 21 May 2021
Revised: 27 May 2021
Accepted: 3 June 2021
First Online: 28 July 2021
COMPETING INTERESTS
: LD, IG, and CP are employees of Novartis. SA has acted as a consultant or advisor for Novartis and Daiichi-Sankyo. BCM has acted as a consultant or advisor for Celgene, Novartis, and Astellas and is currently employed by Roche/Genentech. MST has acted as a consultant or advisor for AbbVie, BioLineRx, Daiichi-Sankyo, Orsenix, KAHR Medical, Rigel Pharmaceuticals, Nohla, Delta Fly Pharma, Tetraphase, Oncolyze, and Jazz Pharmaceuticals; has received clinical research funding from AbbVie, Cellerant Therapeutics, Orsenix, ADC Therapeutics, and BioSight; and has received royalties from UpToDate. JS has acted as a consultant or advisor for Pfizer, Daiichi Sankyo, AbbVie, Novartis, Astellas, and Roche and is a member of the speakers bureau for Novartis, Pfizer, Daiichi Sankyo, and AbbVie. MAS has acted as a consultant or advisor for Teva Pharmaceutical Industries, Daiichi-Sankyo, Orsenix, AbbVie, Novartis, and Pfizer. DN has acted as consultants or advisors for Novartis. MH has acted as a consultant or advisor for AbbVie, Daiichi Sankyo, Novartis, Pfizer, and Bayer Pharma and has received clinical research support from Pfizer, Daiichi Sankyo, Karyopharm, BerGenBio, Bayer Pharma, Novartis, and Astellas. AG has received clinical research support from Novartis. LB has acted as an advisor for Abbvie, Amgen, Astellas, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Sanofi, Seattle Genetics. RAL has acted as a consultant or advisor and has received clinical research support from Novartis. RMS has acted as a consultant or advisor for AbbVie, Actinium, and Agios; has received personal fees from Amgen, argenx, AROG, Astellas, AstraZeneca, BioLineRx, Celgene, Cornerstone, Daiichi-Sankyo, Fujifilm, Jazz Pharmaceuticals,MacroGenics, Novartis, Ono/Theradex Oncology, Orsenix, Otsuka/Astex, Pfizer, Roche, Stemline Therapeutics, Takeda, and Trovagene; and has received institutional research support from AbbVie, Agios, AROG, and Novartis. HD has acted as a consultant or advisor for AbbVie, Agios, Amgen, Astellas, Astex Pharmaceuticals, Celgene, Janssen, Jazz Pharmaceuticals, Novartis, Roche, and Seattle Genetics and has received institutional research support from Amgen, AROG Pharmaceuticals, Bristol-Myers Squibb, Celgene, Jazz Pharmaceuticals, Novartis, Pfizer, and Sunesis. CT is the Chief Executive Officer and a co-owner of Agendix, a company performing molecular diagnostics; has acted as a consult or advisor for Novartis and Astellas; and has received clinical research support from Bayer. KD has acted as a consultant or advisor for Astellas, Celgene, Daiichi Sankyo, Janssen, Novartis, and Roche and has received clinical research support from Astex, Celgene, and Novartis. The remaining authors declare no competing financial interests. Clara D. Bloomfield died on 1 March 2020.